ClinConnect ClinConnect Logo
Search / Trial NCT06895161

Home-Based Tele-Exercise vs. Hospital-Based Exercise Programs in Patients With Prediabetes

Launched by GAZI UNIVERSITY · Mar 24, 2025

Trial Information

Current as of April 29, 2025

Active, not recruiting

Keywords

Prediabetes Telemedicine Telerehabilitation Aerobic Exercise

ClinConnect Summary

This clinical trial is studying the effects of two different exercise programs on people with prediabetes, a condition where blood sugar levels are higher than normal but not high enough to be considered diabetes. The trial compares "tele-exercise," where participants exercise at home using a heart rate monitor, with a "hospital-based exercise" program that takes place under supervision in a hospital setting. Both groups will engage in aerobic exercises, like walking, for 30 minutes a day, five days a week over three weeks. There is also a control group that will do the same exercises at home without any monitoring.

To be eligible for this study, participants need to be between 18 and 80 years old and have been diagnosed with prediabetes based on specific blood sugar tests. They should not be doing a lot of exercise already or using insulin or diabetes medications. This trial is currently active but not recruiting new participants. If someone qualifies and joins, they can expect to follow a structured exercise plan and help researchers understand how different exercise environments might affect their health, including their fitness, blood sugar control, and overall well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Accepting to participate in the study
  • ≥18 and \<80 years of age
  • With oral glucose tolerance test (after 75 g oral glucose) 2nd hour glucose value: 140-199 mg/dl or fasting blood glucose : 100-125 mg/dl and diagnosed as prediabetes by an endocrinologist
  • Exclusion Criteria:
  • High physical activity: Performing ≥150 minutes of moderate-intensity exercise per week
  • Using insulin or oral antidiabetics
  • Presence of cardiac and physical conditions that would prevent aerobic exercise
  • Presence of neurological disease with significant sensorimotor deficit
  • Presence of active malignancy
  • Neuropsychiatric disease or condition that may prevent cooperation

About Gazi University

Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Çise C Güngör, MD

Principal Investigator

Gazi University Faculty of Medicine

Nesrin Ü Demirsoy, MD

Principal Investigator

Gazi University Faculty of Medicine

Levent Karataş, MD

Principal Investigator

Gazi University Faculty of Medicine

Muhittin M Yalçın, MD

Principal Investigator

Gazi University Faculty of Medicine

Levent A Güngör, MD

Principal Investigator

Gazi University Faculty of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported